APA Alıntı

Banys-Paluchowski, M., Fehm, T., Janni, W., Aktas, B., Fasching, P. A., Kasimir-Bauer, S., . . . Müller, V. (2018). Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer. BMC Cancer.

Chicago Stili Alıntı

Banys-Paluchowski, Malgorzata, et al. "Elevated Serum RAS P21 Is an Independent Prognostic Factor in Metastatic Breast Cancer." BMC Cancer 2018.

MLA Alıntı

Banys-Paluchowski, Malgorzata, et al. "Elevated Serum RAS P21 Is an Independent Prognostic Factor in Metastatic Breast Cancer." BMC Cancer 2018.